A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaWinnie Yeo, Philip J. Johnson, Benny Zee et al.|JNCI Journal of the National Cancer Institute|2005Cited by 591